Sign in

CIK 0001533040 · Non-accelerated filer<br>Smaller reporting company

Phio Pharmaceuticals Corp.

Sign in to watch
Ticker
PHIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
453215903
Phone
(508) 767-3861
Business address
411 SWEDELAND ROAD, SUITE 23-1080, KING OF PRUSSIA, PA, 19406
Former names
RXi Pharmaceuticals Corp
Open-market buys, last 90 days
$104,806
in 9 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$104,806. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-03-01 Kontulis Caitlin Secretary & VP Finance & Admin Grant or award +34,600 39,826
2020-08-19 Dispersyn Gerrit President & CEO Purchase +2,000 $2.50 $5K 16,377
2020-03-01 Dispersyn Gerrit President & CEO Shares withheld for taxes −673 $2.93 $2K 14,628
2019-11-18 Bitterman Robert J Director Grant or award +300,000 $0.10 $30K 320,440
2019-11-18 Dispersyn Gerrit President & CEO Grant or award +350,000 $0.10 $35K 827,817
2019-11-18 Kontulis Caitlin Secretary & VP Finance & Admin Grant or award +237,500 $0.10 $24K 279,030
2019-11-18 CAUWENBERGH GEERT Director Grant or award +225,000 $0.10 $23K 704,841
2019-11-18 Ferrara Robert L Director Grant or award +127,500 $0.10 $13K 127,500
2019-08-01 CAUWENBERGH GEERT Director Shares withheld for taxes −1,751 $0.40 $706 479,841
2019-08-01 Dispersyn Gerrit President & CEO Shares withheld for taxes −1,236 $0.40 $498 477,817
2019-08-01 Kontulis Caitlin Secretary & VP Finance & Admin Shares withheld for taxes −749 $0.40 $302 41,530
2019-04-22 Barrett John A Chief Development Officer Grant or award +222,991 222,991

Page 6 of 6 · 112 trades